An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
NCT ID: NCT00932893
Last Updated: 2017-01-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
347 participants
INTERVENTIONAL
2009-09-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
NCT00932451
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
NCT02604342
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
NCT00254891
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
NCT01441128
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
NCT00548093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PF-02341066
PF-02341066
PF-02341066, 250 mg BID will be administered orally on a continuous schedule
Pemetrexed or Docetaxel
Investigator selection of either pemetrexed or docetaxel as the active comparator
Pemetrexed
Pemetrexed, 500 mg/m\^2, will be administered by i.v. infusion over 10 minutes on Day 1 of each 21-day cycle
Docetaxel
Docetaxel, 75 mg/m\^2, will be administered by i.v. infusion over 1 hour on Day 1 of each 21-day cycle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PF-02341066
PF-02341066, 250 mg BID will be administered orally on a continuous schedule
Pemetrexed
Pemetrexed, 500 mg/m\^2, will be administered by i.v. infusion over 10 minutes on Day 1 of each 21-day cycle
Docetaxel
Docetaxel, 75 mg/m\^2, will be administered by i.v. infusion over 1 hour on Day 1 of each 21-day cycle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* positive for the ALK fusion gene (test provided by a central laboratory)
* must have had disease progression after only one prior chemotherapy and that regimen but must have included one platinum drug
* tumors must be measurable
Exclusion Criteria
* current treatment in another clinical trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Research, Winthrop Rockefeller Cancer Institute
Little Rock, Arkansas, United States
Comprehensive Blood and Cancer Center
Bakersfield, California, United States
Tower Cancer Research Foundation
Beverly Hills, California, United States
Tower Hematology Oncology Medical Group
Beverly Hills, California, United States
UCSD Medical Center -La Jolla
La Jolla, California, United States
Moores UC San Diego Cancer Center
La Jolla, California, United States
Drug Shipping Address: [IRB# 10-001530] Ronald Reagan UCLA
Los Angeles, California, United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States
UCLA Hematology Oncology
Los Angeles, California, United States
UCLA Ophthalmic Oncology Center
Los Angeles, California, United States
University of California-Los Angeles
Los Angeles, California, United States
Ship Drug To : Kevin Kong- University of California, Irvine-Pharmacy
Orange, California, United States
University of California, Irvine-Medical Center
Orange, California, United States
Stanford University-Cancer Center
Palo Alto, California, United States
UC Davis Cancer Center
Sacramento, California, United States
University of California Davis Medical Center
Sacramento, California, United States
UCSD Medical Center- Hillcrest
San Diego, California, United States
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Santa Monica, California, United States
University of California, Los Angeles
Santa Monica, California, United States
Redwood Regional Medical Group, Inc.
Santa Rosa, California, United States
Drug Shipment: University of Colorado Cancer Center, Anschutz Cancer Pavilion
Aurora, Colorado, United States
University of Colorado Denver (CTRC)
Aurora, Colorado, United States
Unviersity of Colorado Hospital, Anschutz Cancer Pavilion
Aurora, Colorado, United States
Unviersity of Colorado Hospital, Anschutz Inpatient Pavilion
Aurora, Colorado, United States
Kaiser Permanente
Denver, Colorado, United States
Kaiser Permanente
Lafayette, Colorado, United States
Drug Shipping for Yale; C/O Thomas Ferencz, RPh, BCOP
New Haven, Connecticut, United States
Smilow Cancer Hospital at Yale New Haven
New Haven, Connecticut, United States
Clinical Trial Office
New Haven, Connecticut, United States
Yale Cancer Center
New Haven, Connecticut, United States
Memorial Cancer Institute
Hollywood, Florida, United States
Cancer Center of South Florida Foundation, Inc.
Lake Worth, Florida, United States
Memorial Cancer Institute (West)
Pembroke Pines, Florida, United States
H Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
Emory Clinic
Atlanta, Georgia, United States
Emory University Clinic
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Winship Cancer Institution
Atlanta, Georgia, United States
Georgia Cancer Specialists-Administrative Annex
Atlanta, Georgia, United States
Georgia Cancer Specialists - Stemmer
Decatur, Georgia, United States
Georgia Cancer Specialists-Macon
Macon, Georgia, United States
Georgia Cancer Specialists-Kennestone
Marietta, Georgia, United States
Georgia Cancer Specialists
Sandy Springs, Georgia, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
Hawaii Medical Center East
Honolulu, Hawaii, United States
OnCare Hawaii, Inc.
Honolulu, Hawaii, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Ingalls Memorial Hospital (Drug Shipment Only)
Harvey, Illinois, United States
Ingalls Memorial Hospital
Harvey, Illinois, United States
Monroe Medical Associates
Harvey, Illinois, United States
Monroe Medical Associates
Tinley Park, Illinois, United States
Indiana University Hospital
Indianapolis, Indiana, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Ship Drug to: Investigational Drug Services
Indianapolis, Indiana, United States
Wishard Memorial Hospital
Indianapolis, Indiana, United States
Springmill Medical Clinic
Indianapolis, Indiana, United States
Monroe Medical Associates
Munster, Indiana, United States
The Community Hospital
Munster, Indiana, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
Massachusette General Hospital
Boston, Massachusetts, United States
Massachussetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Beth Isreal Deaconess Medical Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
DFCI/Pharmacy (Drug Shipment Only)
Boston, Massachusetts, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
Lawrence and Idell Weisberg Cancer Treatment Center
Farmington Hills, Michigan, United States
Siteman Cancer Center
City of Saint Peters, Missouri, United States
Siteman Cancer Center- West County
Creve Coeur, Missouri, United States
Barnes-Jewish Hospital
St Louis, Missouri, United States
Washington University, School of Medicine
St Louis, Missouri, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
NSLIJ Health System/Monter Cancer Center
Lake Success, New York, United States
Memorial Sloan-Kettering Cancer Center: Rockefeller Outpatient Pavilion
New York, New York, United States
Columbia University Medical Center
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians
Oneida, New York, United States
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians
Oswego, New York, United States
SUNY Upstate Medical University
Syracuse, New York, United States
Department of Medicine MSG at SUNY HSC at Syracuse, INC., d/b/a University Physicians
Syracuse, New York, United States
Investigational Drug Service, Pharmacy Department, UNC Hospitals
Chapel Hill, North Carolina, United States
UNC Health Care, NC Cancer Hospital Infusion/lnpatient Pharmacy (CHIP)
Chapel Hill, North Carolina, United States
UNC Hospitals
Chapel Hill, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
The Ohio State University Hospital East
Columbus, Ohio, United States
The Ohio State University James Cancer Hospital and Solove Research Institute
Columbus, Ohio, United States
James Care in Kenny
Columbus, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute
Hershey, Pennsylvania, United States
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center-Shadyside
Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Vincent Armenio, MD
East Providence, Rhode Island, United States
Pharma Resource
East Providence, Rhode Island, United States
Tennessee Oncology, PLLC
Dickson, Tennessee, United States
Tennessee Oncology, PLLC
Franklin, Tennessee, United States
Tennessee Oncology, PLLC
Gallatin, Tennessee, United States
Tennessee Oncology, PLLC
Hermitage, Tennessee, United States
Tennessee Oncology, PLLC
Lebanon, Tennessee, United States
Tennessee Oncology, PLLC
Murfreesboro, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Nashville, Tennessee, United States
The Vanderbilt Cancer Clinic
Nashville, Tennessee, United States
The Vanderbilt Chemo Pharmacy
Nashville, Tennessee, United States
Tennessee Oncology, PLLC
Smyrna, Tennessee, United States
The University of Texas
Houston, Texas, United States
Swedish Cancer Institute
Seattle, Washington, United States
Seattle Cancer Care Alliance
Seattle, Washington, United States
Investigational Drug Service
Seattle, Washington, United States
Swedish Medical Center
Seattle, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
Sydney Cancer Centre
Camperdown, New South Wales, Australia
Royal Adelaide Hospital, Department of Medical Oncology
Adelaide, South Australia, Australia
Peter MacCallum Cancer Centre, Division of Haematology and Medical Oncology
East Melbourne, Victoria, Australia
Department of Medical Oncology
Nedlands, Western Australia, Australia
Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, Brazil
Instituto Nacional de Câncer - INCA
Rio de Janeiro, Rio de Janeiro, Brazil
Associacao Hospital de Caridade de Ijui
Ijuí, Rio Grande do Sul, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sao Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Fundacao Pio XII Hospital de Cancer de Barretos
Barretos, São Paulo, Brazil
Fundacao Hospital Amaral Carvalho
Jaú, São Paulo, Brazil
Instituto do Câncer de São Paulo "Octavio Frias de Oliveira" - ICESP
São Paulo, São Paulo, Brazil
Fundacao Antonio Prudente
São Paulo, São Paulo, Brazil
UMBAL "Tsaritsa Yoanna - ISUL", Klinika po onkoterapiya
Sofia, Bulgaria, Bulgaria
Spetsializirana Bolnitsa za Aktivno Lechenie po Onkologiya, Klinika po himioterapiya
Sofia, Bulgaria, Bulgaria
MDOZS Plovdiv EOOD; Parvo vatreshno himioterapevtichno otdelenie
Plovdiv, , Bulgaria
MBAL Voennomeditsinska Academia, MMA HAT Sofia
Sofia, , Bulgaria
MDOZS "Dr. Marko Markov", Otdelenie po onkoterapiya i paliativni grizhi
Varna, , Bulgaria
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Alberta Health Services, Holy Cross Site
Calgary, Alberta, Canada
Office of Dr. John McWhae
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Dr. Georges-L. Dumont Regional Hospital
Moncton, New Brunswick, Canada
Dr. Leon Richard Oncology Centre
Moncton, New Brunswick, Canada
RSM Durham Regional Cancer Centre
Oshawa, Ontario, Canada
Dr. Dana Blakolmer and Associates
Oshawa, Ontario, Canada
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Hopital Notre-Dame du Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, Canada
Royal Victoria Hospital
Montreal, Quebec, Canada
Montreal General Hospital
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
St. Mary's Hospital Center
Montreal, Quebec, Canada
SUN Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Guangdong General Hospital
Guangzhou, Guangdong, China
Nanjing Bayi Hospital
Nanjing, Jiangsu, China
Cancer Institute and Hospital Chinese Academy of Medical Sciences and PUMC
Beijing, , China
307 Hospital of PLA
Beijing, , China
Shanghai Chest Hospital/Department of Pulmonary Medicine
Shanghai, , China
Shanghai Chest Hospital
Shanghai, , China
Zhongshan Hospital Fudan University / Respiratory Department
Shanghai, , China
Shanghai Pulmonary Hospital/Dept. of Oncology
Shanghai, , China
Centre Francois Baclesse
Caen, , France
Centre Georges-François Leclerc
Dijon, , France
Hopital Albert Michallon
Grenoble, , France
Pr Fabrice BARLESI
Marseille, , France
Centre Antoine Lacassagne
Nice, , France
Groupe Hospitalier Cochin
Paris, , France
Hopital Tenon / Service de Pneumologie
Paris, , France
Centre Rene Gauducheau / Service d'Oncologie Medicale
Saint-Herblain, , France
Institut Gustave Roussy
Villejuif, , France
Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin
Cologne, , Germany
Universitaetsklinik Carl-Gustav-Carus Dresden
Dresden, , Germany
Westdeutsches Tumorzentrum, Universitaetsklinikum Essen, Innere Klinik - Tumorforschung
Essen, , Germany
Krankenhaus Grosshansdorf, Zentrum fuer Pneumologie und Thoraxchirurgie
Großhansdorf, , Germany
MVZ Prof. Mathey, Pfrof. Schofer GmbH
Hamburg, , Germany
Thoraxklinik am Universitaetsklinikum Heidelberg, Internistische Onkologie der Thoraxtumoren
Heidelberg, , Germany
Klinikum der Universitaet Muenchen, Medizinische Klink - Innenstadt, Pneumologie
München, , Germany
Pius-Hospital Oldenburg
Oldenburg, , Germany
HSK Dr.- Horst-Schmidt-Kliniken, Innere Medizin III Haematologie, Onkologie, Palliativmedizin
Wiesbaden, , Germany
University General Hospital of Heraklion/ Department of Clinical Oncology
Heraklion, Crete, Greece
General Hospital of Thessaloniki Georgios Papanikolaou, Lung Cancer Neoplasia Research Department
Eksochi, Thessaloniki, Greece
General Hospital of Chest Diseases of Athens "Sotiria"
Athens, , Greece
Tuen Mun Hospital, Department of Clinical Oncology
Tuenmen, New Territories, Hong Kong
Division of Respiratory and Critical Care Medicine, Department of Medicine, Queen Mary Hospital
Pokfulam, , Hong Kong
Department of Clinical Oncology, Prince of Wales Hospital
Shatin, New Territories, , Hong Kong
Orszagos Koranyi TBC és Pulmonologiai Intezet, VI. Bronchologia
Budapest, , Hungary
Semmelweis Egyetem Pulmonologia Intezet
Budapest, , Hungary
Debreceni Egyetem Orvos- és Egészségtudományi Centrum, Tudogyogyaszati Klinika
Debrecen, , Hungary
Veszprem Megyei Onkormanyzat Tudogyogyintezete
Farkasgyepű, , Hungary
Fejer Megyei Szent Gyorgy Korhaz, Pulmonologiai Osztaly
Székesfehérvár, , Hungary
Pest Megyei Tudogyogyintezet, III. Osztaly
Törökbálint, , Hungary
Aseptic Compounding Unit
Dublin, , Ireland
Department of Medical Oncology
Dublin, , Ireland
Department of Medical Oncology
Galway, , Ireland
Merlin Park Imaging Centre
Galway, , Ireland
Pharmacy Aseptic Service Unit
Galway, , Ireland
A.O. di Rilievo Nazionale e di Alta Specialita - S. G. Moscati
Avellino, , Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, , Italy
Oncologia Medica A
Genova, , Italy
Ospedale Versilia, Oncologia Medica
Lido Di Camaiore (LU), , Italy
Ospedale San Luca
Lucca, , Italy
Dipartimento Oncologia Medica, UO Medicina 1Q A, Unita' Nuovi Farmaci e Terapie Innovative
Milan, , Italy
Istituto Europeo di Oncologia IRCCS
Milan, , Italy
Ospedale Niguarda Ca' Granda Dipartimento Oncologico, SC Divisione di Oncologia Medica Falk
Milan, , Italy
Nuovo Ospedale San Gerardo
Monza, , Italy
Azienda Ospedaliera Universitaria San Luigi Gonzaga
Orbassano (TO), , Italy
SC Oncologia Medica, Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia
Perugia, , Italy
Unita' Operativa Complessa di Pneumologia Oncologica I, Padiglione Flaiani
Roma, , Italy
Centro C.O.E.S., A.O. San Giovanni Battista Le Molinette
Torino, , Italy
Aichi cancer center central hospital
Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East
Kashiwa, Chiba, Japan
National Kyushu Cancer Center
Fukuoka, Fukuoka, Japan
National Hospital Organization Hokkaido Cancer Center
Sapporo, Hokkaido, Japan
Hyogo Cancer Center
Akashi, Hyōgo, Japan
Okayama University Hospital
Okayama, Okayama-ken, Japan
Kinki University Hospital
Osakasayama-shi, Osaka, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of JFCR
Tokyo, , Japan
Universitair Medisch Centrum Groningen
Groningen, , Netherlands
Pracownia Optyczna Bozena Lawrynowicz Optyk Dyplomowany
Olsztyn, NAP, Poland
Centrum Medyczne Ars Medica
Olsztyn, NAP, Poland
Wojewodzki Szpital Specjalistyczny w Olsztynie
Olsztyn, NAP, Poland
Pracownia Tomografii Komputerowej "ALL MEDI" Sp. z o.o.
Otwock, Poland, Poland
Klinika Onkologii i Radioterapii
Gdansk, , Poland
Uniwersyteckie Centrum Kliniczne
Gdansk, , Poland
Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc
Olsztyn, , Poland
Centralna Izba Przyjec Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy
Otwock, , Poland
Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
Poznan, , Poland
Zaklad Diagnostyki Obrazowej
Poznan, , Poland
Lux Med. Sp.z o.o
Warsaw, , Poland
Republican Clinical Oncology Dispensary of the Ministry of Health of Tatarstan Republic
Kazan', , Russia
State Institution "National Cancer Research Center named after N.N. Blokhin' RAMS"
Moscow, , Russia
City Clinical Oncology Dispensary
Saint Petersburg, , Russia
Saint-Petersburg State Medical University named after I.P.Pavlov of Roszdrav
Saint Petersburg, , Russia
City Clinical Oncology Dispensary
Saint Petersburg, , Russia
Research Institute of Pulmonology
Saint-Peterburg, , Russia
State Medical Institution "Oncology Center #2" of Healthcare Department of Krasnodar Region
Sochi, , Russia
National Cancer Center, Center for Lung Cancer
Goyang-si, Gyeonggi-do, South Korea
Seoul National University Hospital / Department of Internal Medicine
Seoul, , South Korea
Samsung MedicaCenter,SungkyunkwanUnivSchoolofMedicine,Div. of Hematology-Oncology, Dep. of Medicine
Seoul, , South Korea
Complexo Hospitalario Universitario A Coruña. Hospital Teresa Herrera (Materno-Infantil)
A Coruña, A Coruña, Spain
Hospital Universitari Germans Trias I Pujol
Badalona, Barcelona, Spain
Hospital Del Mar
Barcelona, Barcelona, Spain
Hospital General Universitari Vall D´Hebron
Barcelona, Barcelona, Spain
Institut Catala Doncologia - Hospital Duran I Reynals
L'Hospitalet de Llobregat, Barcelona, Spain
Consorcio Hospitalario Parc Tauli
Sabadell, Barcelona, Spain
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain
Hospital Universitario La Paz
Madrid, Madrid, Spain
Hospital de Navarra
Pamplona, Navarre, Spain
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Hospital Universitario Virgen Del Rocio
Seville, Sevilla, Spain
Karolinska Universitetssjukhuset, Onkologiska kliniken
Stockholm, , Sweden
National Cheng Kung University Hospital
Tainan City, , Taiwan
National Taiwan University Hospital, Department of Internal Medicine
Taipei, , Taiwan
Taipei Veterans General Hospital, Chest Department
Taipei, , Taiwan
Royal Marsden Hospital
Sutton, Surrey, United Kingdom
The Alexandra Hospital
Cheshire, , United Kingdom
Nuffield Health Wessex Hospital
Eastleigh, , United Kingdom
Royal Free Hospital
London, , United Kingdom
Kings College London at Guy's Hospital
London, , United Kingdom
Royal Marsden Hospital
London, , United Kingdom
Christie Hospital NHS Trust, Department of Medical Oncology
Manchester, , United Kingdom
Cancer and Haematology Centre,
Oxford, , United Kingdom
Southampton University Hospitals NHS Trust
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Camidge DR, Kim EE, Usari T, Polli A, Lewis I, Wilner KD. Renal Effects of Crizotinib in Patients With ALK-Positive Advanced NSCLC. J Thorac Oncol. 2019 Jun;14(6):1077-1085. doi: 10.1016/j.jtho.2019.02.015. Epub 2019 Feb 26.
Wilner KD, Usari T, Polli A, Kim EE. Comparison of cardiovascular effects of crizotinib and chemotherapy in ALK-positive advanced non-small-cell lung cancer. Future Oncol. 2019 Apr;15(10):1097-1103. doi: 10.2217/fon-2018-0869. Epub 2019 Jan 17.
Yoneda KY, Scranton JR, Cadogan MA, Tassell V, Nadanaciva S, Wilner KD, Stollenwerk NS. Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials. Clin Lung Cancer. 2017 Sep;18(5):472-479. doi: 10.1016/j.cllc.2017.03.004. Epub 2017 Mar 14.
Lin YT, Yu CJ, Yang JC, Shih JY. Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review. Clin Lung Cancer. 2016 Sep;17(5):e77-e94. doi: 10.1016/j.cllc.2016.03.005. Epub 2016 Mar 30.
Costa DB, Shaw AT, Ou SH, Solomon BJ, Riely GJ, Ahn MJ, Zhou C, Shreeve SM, Selaru P, Polli A, Schnell P, Wilner KD, Wiltshire R, Camidge DR, Crino L. Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases. J Clin Oncol. 2015 Jun 10;33(17):1881-8. doi: 10.1200/JCO.2014.59.0539. Epub 2015 Jan 26.
Lin YT, Wang YF, Yang JC, Yu CJ, Wu SG, Shih JY, Yang PC. Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer. J Thorac Oncol. 2014 Nov;9(11):1720-5. doi: 10.1097/JTO.0000000000000326.
Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Janne PA. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013 Jun 20;368(25):2385-94. doi: 10.1056/NEJMoa1214886. Epub 2013 Jun 1.
Tamiya A, Okamoto I, Miyazaki M, Shimizu S, Kitaichi M, Nakagawa K. Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. J Clin Oncol. 2013 Jan 1;31(1):e15-7. doi: 10.1200/JCO.2012.43.3730. Epub 2012 Nov 19. No abstract available.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-012595-27
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
A8081007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.